Loading the session
Loading the session
Loading instrument
$20.60
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +19.9% (SPY −1.6%, XLV +13.5%). 3 months: +22.9% (SPY −0.4%, XLV +15.5%). 1 year: +37.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BLCO, SPY and XLV · as of 4 Nov 2026
Closed at $20.60 on 4 Nov 2026: 3.6% below the 52-week high of $21.36 (29 Oct 2026) and 42.7% above the low of $14.44 (20 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $20.60 was 17.5% above its 50-day average ($17.53) and 23.2% above its 200-day average ($16.72). It has closed above the 200-day for 12 sessions, since 20 Oct 2026. The 50-day average crossed above the 200-day on 27 Aug 2026, 48 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
The 14-session relative strength index closed at 77.1 on 4 Nov 2026, its 6th session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
2 Nov 2026 volume of 1.5M shares was 2.0× the average of the 30 sessions before it (751.5K), as the price rose 0.1%. SPY traded 1.2× its own average that session.
Daily volume against a 30-session baseline · as of 2 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.
October 28, 2026
+15.78%April 30, 2025
−15.74%September 16, 2024
+14.47%